These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36795141)

  • 1. The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson's disease.
    Shi J; Wang Y; Chen D; Xu X; Li W; Li K; He J; Su W; Luo Q
    Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1917-1929. PubMed ID: 36795141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonic bacterial composition in Parkinson's disease.
    Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
    Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease.
    Forsyth CB; Shannon KM; Kordower JH; Voigt RM; Shaikh M; Jaglin JA; Estes JD; Dodiya HB; Keshavarzian A
    PLoS One; 2011; 6(12):e28032. PubMed ID: 22145021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model.
    Gorecki AM; Preskey L; Bakeberg MC; Kenna JE; Gildenhuys C; MacDougall G; Dunlop SA; Mastaglia FL; Akkari PA; Koengten F; Anderton RS
    Front Neurosci; 2019; 13():839. PubMed ID: 31440136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Alpha-Synuclein RT-QuIC Products Generated by the Olfactory Mucosa of Patients with Parkinson's Disease and Multiple System Atrophy Induce Inflammatory Responses in SH-SY5Y Cells.
    De Luca CMG; Consonni A; Cazzaniga FA; Bistaffa E; Bufano G; Quitarrini G; Celauro L; Legname G; Eleopra R; Baggi F; Giaccone G; Moda F
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
    Nielsen SD; Pearson NM; Seidler K
    Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker.
    Chung SJ; Kim J; Lee HJ; Ryu HS; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Lee JY; Hong SM; Myung SJ
    Mov Disord; 2016 Feb; 31(2):241-9. PubMed ID: 26686342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease.
    Singh Y; Trautwein C; Romani J; Salker MS; Neckel PH; Fraccaroli I; Abeditashi M; Woerner N; Admard J; Dhariwal A; Dueholm MKD; Schäfer KH; Lang F; Otzen DE; Lashuel HA; Riess O; Casadei N
    Mol Neurodegener; 2023 Jul; 18(1):44. PubMed ID: 37403161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease.
    Emmi A; Sandre M; Russo FP; Tombesi G; Garrì F; Campagnolo M; Carecchio M; Biundo R; Spolverato G; Macchi V; Savarino E; Farinati F; Parchi P; Porzionato A; Bubacco L; De Caro R; Kovacs GG; Antonini A
    Mov Disord; 2023 May; 38(5):885-894. PubMed ID: 36847308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature.
    Schneider SA; Boettner M; Alexoudi A; Zorenkov D; Deuschl G; Wedel T
    Eur J Neurol; 2016 Feb; 23(2):247-61. PubMed ID: 26100920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.
    Sampson TR; Debelius JW; Thron T; Janssen S; Shastri GG; Ilhan ZE; Challis C; Schretter CE; Rocha S; Gradinaru V; Chesselet MF; Keshavarzian A; Shannon KM; Krajmalnik-Brown R; Wittung-Stafshede P; Knight R; Mazmanian SK
    Cell; 2016 Dec; 167(6):1469-1480.e12. PubMed ID: 27912057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease.
    Anis E; Xie A; Brundin L; Brundin P
    Trends Endocrinol Metab; 2022 Feb; 33(2):147-157. PubMed ID: 34949514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
    Vilas D; Iranzo A; Tolosa E; Aldecoa I; Berenguer J; Vilaseca I; Martí C; Serradell M; Lomeña F; Alós L; Gaig C; Santamaria J; Gelpi E
    Lancet Neurol; 2016 Jun; 15(7):708-718. PubMed ID: 27039162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metagenomic identification of gut microbiota distribution on the colonic mucosal biopsy samples in patients with non-alcoholic fatty liver disease.
    Delik A; Dinçer S; Ülger Y; Akkız H; Karaoğullarından Ü
    Gene; 2022 Jul; 833():146587. PubMed ID: 35598686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
    Russo MJ; Orru CD; Concha-Marambio L; Giaisi S; Groveman BR; Farris CM; Holguin B; Hughson AG; LaFontant DE; Caspell-Garcia C; Coffey CS; Mollon J; Hutten SJ; Merchant K; Heym RG; Soto C; Caughey B; Kang UJ
    Acta Neuropathol Commun; 2021 Nov; 9(1):179. PubMed ID: 34742348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy.
    Engen PA; Dodiya HB; Naqib A; Forsyth CB; Green SJ; Voigt RM; Kordower JH; Mutlu EA; Shannon KM; Keshavarzian A
    J Parkinsons Dis; 2017; 7(2):331-346. PubMed ID: 28234259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar α-Synuclein staining in the colon mucosa in patients with Parkinson's disease and controls.
    Antunes L; Frasquilho S; Ostaszewski M; Weber J; Longhino L; Antony P; Baumuratov A; Buttini M; Shannon KM; Balling R; Diederich NJ
    Mov Disord; 2016 Oct; 31(10):1567-1570. PubMed ID: 27324838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of SNCA variants with α-synuclein of gastric and colonic mucosa in Parkinson's disease.
    Chung SJ; König IR; Lohmann K; Hinrichs F; Kim J; Ryu HS; Lee HJ; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Hong SM; Myung SJ; Klein C
    Parkinsonism Relat Disord; 2019 Apr; 61():151-155. PubMed ID: 30424941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories.
    Bargar C; De Luca CMG; Devigili G; Elia AE; Cilia R; Portaleone SM; Wang W; Tramacere I; Bistaffa E; Cazzaniga FA; Felisati G; Legname G; Di Fonzo A; Xu R; Gunzler SA; Giaccone G; Eleopra R; Chen SG; Moda F
    Mol Neurodegener; 2021 Dec; 16(1):82. PubMed ID: 34895275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.